Cargando…

Longitudinal Relationship between the Introduction of Medicinal Cannabis and Polypharmacy: An Australian Real-World Evidence Study

BACKGROUND: Recent studies recommend medicinal cannabis (MC) as a potential treatment for chronic pain (CP) when conventional therapies are not successful; however, data from Australia is limited. This real-world evidence study explored how the introduction of MC related to concomitant medication us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalaba, Maja, Eglit, Graham M. L., Feldner, Matthew T., Washer, Patrizia D., Ernenwein, Tracie, Vickery, Alistair W., Ware, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663249/ https://www.ncbi.nlm.nih.gov/pubmed/36448002 http://dx.doi.org/10.1155/2022/8535207

Ejemplares similares

A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years
por: Vickery, Alistair W., et al.
Publicado: (2022)

Medical cannabis authorization patterns, safety, and associated effects in older adults
por: MacNair, Laura, et al.
Publicado: (2022)

Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec
por: Kalaba, Maja, et al.
Publicado: (2021)

Cannabinoid Profiles in Medical Cannabis Users: Effects of Age, Gender, Symptoms, and Duration of Use
por: Kalaba, Maja, et al.
Publicado: (2022)

Effectiveness and Tolerability of Dronabinol Use in Patients with Chronic Pain: A Retrospective Analysis of 12-Week Open-Label Real-World Data Provided by the German Pain e-Registry
por: Ueberall, Michael A, et al.
Publicado: (2022)

A Longitudinal Observational Study of Medical Cannabis Use and Polypharmacy among Patients Presenting to Dispensaries in Pennsylvania
por: Hajjar, Emily R., et al.
Publicado: (2023)

Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)
por: Lintzeris, Nicholas, et al.
Publicado: (2020)

Real World Evidence in Medical Cannabis Research
por: Banerjee, Rishi, et al.
Publicado: (2021)

Introduction to Cannabis and Cannabinoid Research
por: Piomelli, Daniele
Publicado: (2016)

Introduction to emerging industrial applications of cannabis (Cannabis sativa L.)
por: Sorrentino, Giuseppe
Publicado: (2021)

Survey of Australians using cannabis for medical purposes
por: Swift, Wendy, et al.
Publicado: (2005)

The value of real world evidence: The case of medical cannabis
por: Schlag, Anne Katrin, et al.
Publicado: (2022)

Polypharmacy and trajectories of health-related quality of life in older adults: an Australian cohort study
por: Aljeaidi, Muhamad S., et al.
Publicado: (2022)

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy
por: Siefried, Krista J., et al.
Publicado: (2018)

Ten-Year Trends in Psychotropic Prescribing and Polypharmacy in Australian General Practice Patients with and without Dementia
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2023)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
por: Suraev, A., et al.
Publicado: (2018)

Cannabis Use Among Remote Indigenous Australians: Opportunities to Support Change Identified in Two Waves of Sampling
por: Graham, Veronica E., et al.
Publicado: (2018)

Internet-Delivered Tobacco Treatment for People Using Cannabis: A Randomized Trial in Two Australian Cannabis Clinics
por: Hindson, Josephine, et al.
Publicado: (2020)

Deprescribing in Real Time: Hospitalized Septuagenarian With Polypharmacy
por: Famuyiro, Tolulope, et al.
Publicado: (2023)

Expert advice for prescribing cannabis medicines for patients with epilepsy—drawn from the Australian clinical experience
por: Lawson, John, et al.
Publicado: (2022)

Polypharmacy in the elderly
por: Golchin, Negar, et al.
Publicado: (2015)

Introduction to real-world evidence studies
por: Chodankar, Deepa
Publicado: (2021)

Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens
por: Kardas, Przemysław, et al.
Publicado: (2021)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

POLYPHARMACY IN DIABETIC PEOPLE: EVIDENCE FROM THE ENGLISH LONGITUDINAL STUDY OF AGEING (ELSA)
por: Huang, Yun-Ting, et al.
Publicado: (2019)

The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications
por: Lewis, Monique, et al.
Publicado: (2021)

Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
por: Cairns, Elizabeth A., et al.
Publicado: (2023)

A delicate balance: Psychotropic polypharmacy and anti‐cholinergic use are correlated with fall incidence in Australian inpatients with dementia
por: Tan, Samuel X., et al.
Publicado: (2021)

Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study
por: Zellers, Stephanie M., et al.
Publicado: (2022)

Drug Prescription Profiles in Patients with Polypharmacy in Spain: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data
por: Hernández-Rodríguez, Miguel Ángel, et al.
Publicado: (2021)

Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
por: Tanaka, Fumiaki, et al.
Publicado: (2021)

Association between polypharmacy and falls in older adults: a longitudinal study from England
por: Dhalwani, Nafeesa N, et al.
Publicado: (2017)

Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study
por: Thapaliya, Kailash, et al.
Publicado: (2021)

Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia
por: Stassen, H. H., et al.
Publicado: (2021)

Polypharmacy: Misleading, but manageable
por: Bushardt, Reamer L, et al.
Publicado: (2008)

Polypharmacy among the Elderly
por: Hosseini, Seyed Reza, et al.
Publicado: (2018)

Polypharmacy in Zoological Medicine
por: Hunter, Robert P., et al.
Publicado: (2017)

Polypharmacy in the Homebound Population
por: Cook, Erin Atkinson, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ckgk4lnggg788307uq44esg1m